Flynn Daniel Lee - Insider Non-Derivative Transactions at Deciphera Pharmaceuticals, Inc. (DCPH) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 16, 2023, Flynn Daniel Lee's relationship to Deciphera Pharmaceuticals, Inc. (DCPH) is Officer (Chief Scientific Officer), and currently has 57,158 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other DCPH insiders.
Data Source: SEC.
Flynn Daniel Lee - Insider Non-Derivative Transactions of DCPH Common Stock
Flynn Daniel Lee - Insider Non-Derivative Transactions at DCPH
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 17, 2023 | Sell -- (Common Stock) | 1655 | 14.4 | 57158 |
| Feb 17, 2023 | Sell -- (Common Stock) | 1370 | 15.1 | 58813 |
| Feb 16, 2023 | Acquisition -- (Common Stock) | 16488 | 0 | 60183 |
| Jan 18, 2023 | Sell -- (Common Stock) | 2403 | 21.24 | 43695 |